Literature DB >> 9633537

Estrogen treatment induces elevated expression of HMG1 in MCF-7 cells.

K Y Chau1, H Y Lam, K L Lee.   

Abstract

The high mobility group (HMG) 1 protein is a highly conserved and ubiquitous chromosomal protein found enriched in active chromatin. In this study, we have investigated the effect of estrogen on the expression of the human high mobility group protein HMG1 gene and found that the HMG1 mRNA level in MCF-7 cells was sharply increased 2.5-fold after 30 min of estrogen treatment. Under continuous estrogen treatment, the HMG1 mRNA level decreased to a 1.5 times that of the basal level at 90 min and remained at this elevated level under estrogen treatment for up to 24 h. These results support the recent finding by Verrier et al. (C.S. Verrier, 1997, Mol. Endocrinol. 11, 1009-1019) that HMG1 promotes the binding of the estrogen receptor to the estrogen response element and further reinforce our believe that HMG1 plays a significant role in estrogen-induced gene expression.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9633537     DOI: 10.1006/excr.1998.4052

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  11 in total

1.  HMG-D complexed to a bulge DNA: an NMR model.

Authors:  R Cerdan; D Payet; J C Yang; A A Travers; D Neuhaus
Journal:  Protein Sci       Date:  2001-03       Impact factor: 6.725

2.  Non-traditional platinum compounds for improved accumulation, oral bioavailability, and tumor targeting.

Authors:  Katherine S Lovejoy; Stephen J Lippard
Journal:  Dalton Trans       Date:  2009-10-01       Impact factor: 4.390

3.  Steroid hormones induce HMG1 overexpression and sensitize breast cancer cells to cisplatin and carboplatin.

Authors:  Q He; C H Liang; S J Lippard
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

4.  Metastasis-associated protein 1 interacts with NRIF3, an estrogen-inducible nuclear receptor coregulator.

Authors:  Amjad H Talukder; Anupama Gururaj; Sandip K Mishra; Ratna K Vadlamudi; Rakesh Kumar
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

Review 5.  Regulation of energy metabolism pathways by estrogens and estrogenic chemicals and potential implications in obesity associated with increased exposure to endocrine disruptors.

Authors:  Jin-Qiang Chen; Terry R Brown; Jose Russo
Journal:  Biochim Biophys Acta       Date:  2009-04-05

Review 6.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

Review 7.  Current Developments in Pt(IV) Prodrugs Conjugated with Bioactive Ligands.

Authors:  Xuejiao Li; Yahong Liu; Hongqi Tian
Journal:  Bioinorg Chem Appl       Date:  2018-10-01       Impact factor: 7.778

8.  Effects of HMGB-1 overexpression on cell-cycle progression in MCF-7 cells.

Authors:  Sarah Yoon; Jin Young Lee; Byung-Koo Yoon; Duk Soo Bae; Doo Seok Choi
Journal:  J Korean Med Sci       Date:  2004-06       Impact factor: 2.153

9.  Bench-to-bedside review: High-mobility group box 1 and critical illness.

Authors:  Mitchell P Fink
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

Review 10.  High-Mobility Group Box-1 and Liver Disease.

Authors:  Harriet Gaskell; Xiaodong Ge; Natalia Nieto
Journal:  Hepatol Commun       Date:  2018-09-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.